Ligand Identification for Orphan MHC-Agnostic T-Cell Receptors by Whole Genome CRISPR-Cas9 Screening

Michael D Crowther1,2, Mateusz Legut1,3, Andrew K Sewell4

  • 1Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.

Insights

Killer T-cells are crucial for immunity, detecting threats inside cells. This study introduces a new unbiased method for discovering T-cell receptor ligands, expanding our understanding of immune responses beyond conventional pathways.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Killer T-cells are vital for immune responses against infections and cancer.
  • They typically identify intracellular anomalies via peptides presented by Major Histocompatibility Complex (MHC) molecules.
  • Emerging evidence suggests T-cells can detect intracellular changes through non-MHC pathways.

Purpose of the Study:

  • To develop and present an unbiased methodology for discovering T-cell receptor (TCR) ligands.
  • To enable the identification of novel TCR-antigen interactions independent of prior knowledge.

Main Methods:

  • The study describes a novel, unbiased approach for T-cell receptor ligand discovery.
  • This methodology does not require pre-existing information about the antigen's nature.

Main Results:

  • The developed methodology allows for the identification of T-cell receptor ligands.
  • It provides a new tool for exploring immune recognition pathways beyond conventional MHC-restricted antigen presentation.

Conclusions:

  • The described unbiased methodology facilitates the discovery of T-cell receptor ligands.
  • This approach broadens the scope of understanding T-cell recognition of pathogens and cancer cells, including non-MHC mediated responses.

Related Concept Videos